Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Tuire Granules (感冒退热颗粒) is an approved traditional Chinese medicine (TCM) formulation developed and manufactured by Jiangsu Tiansheng Pharmaceutical Co., Ltd. for the treatment of the common cold and associated fever. Administered orally in granule form, the product is designed to relieve upper respiratory symptoms through traditional heat-clearing and detoxifying properties. Jiangsu Tiansheng Pharmaceutical, established in 2001, specializes in natural plant extracts and TCM products. While the specific herbal composition and molecular mechanism of action for this proprietary formulation are not publicly detailed in modern pharmacological terms, it represents a standard TCM approach to managing viral respiratory symptoms and fever in the Chinese market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ganmao tuire granules.